LuMind IDSC and the Down Syndrome Clinical Trials Network are pleased to announce the launch…
CapetivateNovember 16, 2022
n a study led by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an…
CapetivateJanuary 26, 2022
Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies about Down syndrome-related…
CapetivateJanuary 25, 2022
During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that the development…
CapetivateJanuary 12, 2022
LuMind IDSC, the National Down Syndrome Society (NDSS), and the National Task Group on Intellectual…
CapetivateOctober 20, 2021
Dr. Nicole White, Hampus Hillerstrom, LuMind IDSC and a team of experts, recently published an…
CapetivateOctober 18, 2021
Dr. James Hendrix, LuMind IDSC's Chief Scientific Officer, along with a team of Down syndrome…
CapetivateOctober 13, 2021
From mom of four to Down syndrome researcher. Community Spotlight sat with Nicole White and…
CapetivateOctober 7, 2021